Long-QT Syndrome Induced by the Antiaddiction Drug Ibogaine
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Journal
NEW ENGLAND JOURNAL OF MEDICINE
Volume 360, Issue 3, Pages 308-309Publisher
MASSACHUSETTS MEDICAL SOC
Keywords
Categories
Ask authors/readers for more resources
Authors
I am an author on this paper
Reviews
Recommended
Obesity Potentiates the Risk of Drug-Induced Long QT Syndrome-Preliminary Evidence from WNIN/Ob Spontaneously Obese Rat
Ajay Godwin Potnuri, Kallamadi Prathap Reddy, Pothani Suresh, Gulam Mohammed Husain, Munawwar Husain Kazmi, Nemani Harishankar
CARDIOVASCULAR TOXICOLOGY (2021)
Genetic and Molecular Aspects of Drug-Induced QT Interval Prolongation
Daniela Baracaldo-Santamaria, Kevin Llinas-Caballero, Julian Miguel Corso-Ramirez, Carlos Martin Restrepo, Camilo Alberto Dominguez-Dominguez, Dora Janeth Fonseca-Mendoza, Carlos Alberto Calderon-Ospina
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
A Novel KCNH2 S981fs Mutation Identified by Whole-Exome Sequencing Is Associated with Type 2 Long QT Syndrome
Yu-Wen Cheng, Chia-Tung Wu, Chi-Jen Chang, Yung-Hsin Yeh, Gwo-Jyh Chang, Hsin-Yi Tsai, Lung-An Hsu
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Targeted activation of human ether-a-go-go-related gene channels rescues electrical instability induced by the R56Q+/- long QT syndrome variant
Ravichandra Venkateshappa, Diana Hunter, Priya Muralidharan, Raghu S. Nagalingam, Galvin Huen, Shoaib Faizi, Shreya Luthra, Eric Lin, Yen May Cheng, Julia Hughes, Rania Khelifi, Daman Parduman Dhunna, Raj Johal, Valentine Sergeev, Sanam Shafaattalab, Lisa M. Julian, Damon T. Poburko, Zachary Laksman, Glen F. Tibbits, Tom W. Claydon
CARDIOVASCULAR RESEARCH (2023)
Ventricular fibrillation induced by fever in structurally normal hearts
Ji-Fang Ma, You Zhou, Hai-Xia Fu
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)
The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23
Jose Alberto Navarro-Garcia, Rafael Salguero-Bodes, Laura Gonzalez-Lafuente, Laura Martin-Nunes, Elena Rodriguez-Sanchez, Teresa Bada-Bosch, Eduardo Hernandez, Evangelina Merida-Herrero, Manuel Praga, Jorge Solis, Fernando Arribas, Hector Bueno, Makoto Kuro-O, Maria Fernandez-Velasco, Luis Miguel Ruilope, Carmen Delgado, Gema Ruiz-Hurtado
BMC MEDICINE (2022)
Initiation of ventricular arrhythmia in the acquired long QT syndrome
Cherry Alexander, Martin J. Bishop, Rebecca J. Gilchrist, Francis L. Burton, Godfrey L. Smith, Rachel C. Myles
CARDIOVASCULAR RESEARCH (2023)
Rare Variation in Drug Metabolism and Long QT Genes and the Genetic Susceptibility to Acquired Long QT Syndrome
Belinda Gray, Alban-Elouen Baruteau, Albert A. Antolin, Alan Pittman, Giselle Sarganas, Mariam Molokhia, Marieke T. Blom, Rachel Bastiaenen, Abdenasser Bardai, Silvia G. Priori, Carlo Napolitano, Peter E. Weeke, Saad A. Shakir, Wilhelm Haverkamp, Jordi Mestres, Bo Winkel, Adam A. Witney, Irina Chis-Ster, Ajanthah Sangaralingam, A. John Camm, Jacob Tfelt-Hansen, Dan M. Roden, Hanno L. Tan, Edeltraut Garbe, Miriam Sturkenboom, Elijah R. Behr
CIRCULATION-GENOMIC AND PRECISION MEDICINE (2022)
Mutation location and IKs requlation in the arrhythmic risk of long QT syndrome type 1: the importance of the KCNQ1 S6 region
Peter J. Schwartz, Cristina Moreno, Maria-Christina Kotta, Matteo Pedrazzini, Lia Crotti, Federica Dagradi, Silvia Castelletti, Kristina H. Haugaa, Isabelle Denjoy, Maria A. Shkolnikova, Paul A. Brink, Marshall J. Heradien, Sandrine R. M. Seyen, Roel L. H. M. G. Spatjens, Carla Spazzolini, Paul G. A. Volders
EUROPEAN HEART JOURNAL (2021)
Exercise Induced Worsening of Mechanical Heterogeneity and Diastolic Impairment in Long QT Syndrome
Dafni Charisopoulou, George Koulaouzidis, Lucy F. Law, Annika Rydberg, Michael Y. Henein
JOURNAL OF CLINICAL MEDICINE (2021)
Does sports participation increase risk in patients with long QT syndrome? Results from a large French cohort
Caroline Davydoff, Antoine Andorin, Damien Minois, Marine Arnaud, Mathilde Minier, Frederic Sacher, Raphael Martins, Nicolas Clementy, Jean Baptiste Gourraud, Vincent Probst
EUROPACE (2022)
A New Approach Methodology (NAM) for the Prediction of (Nor)Ibogaine-Induced Cardiotoxicity in Humans
Miaoying Shi, Sebastiaan Wesseling, Hans Bouwmeester, Ivonne M. C. M. Rietjens
ALTEX-ALTERNATIVES TO ANIMAL EXPERIMENTATION (2021)
Individualized QT interval (QTi) is a powerful diagnostic tool in long QT syndrome: results from a large validation study
Tomas Robyns, Dieter Nuyens, Bert Vandenberk, Peter Haemers, Jeroen Breckpot, Christophe Garweg, Joris Ector, Rik Willems
FRONTIERS IN CARDIOVASCULAR MEDICINE (2023)
Long-term sequelae of drug-induced liver injury
Einar S. Bjornsson, Raul J. Andrade
JOURNAL OF HEPATOLOGY (2022)
Prediction of Drug-Induced Long QT Syndrome Using Machine Learning Applied to Harmonized Electronic Health Record Data
Steven T. Simon, Divneet Mandair, Premanand Tiwari, Michael A. Rosenberg
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2021)
The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) and the risk of vascular morbidity and mortality in patients with coronary artery disease
Melvin Lafeber, Wilko Spiering, Yolanda van der Graaf, Hendrik Nathoe, Michiel L. Bots, Diederick E. Grobbee, Frank L. J. Visseren
AMERICAN HEART JOURNAL (2013)
High-dose statin monotherapy versus low-dose statin/ezetimibe combination on fasting and postprandial lipids and endothelial function in obese patients with the metabolic syndrome: The PANACEA study
Jan Westerink, John E. Deanfield, Ben P. Imholz, Wilko Spiering, Dick C. Basart, Blai Coll, John J. P. Kastelein, Frank L. J. Visseren
ATHEROSCLEROSIS (2013)
Persisting gender differences and attenuating age differences in cardiovascular drug use for prevention and treatment of coronary heart disease, 1998-2010
Carla Koopman, Ilonca Vaartjes, Edith M. Heintjes, Wilko Spiering, Ineke van Dis, Ron M. C. Herings, Michiel L. Bots
EUROPEAN HEART JOURNAL (2013)
The impact of susceptibility loci for coronary artery disease on other vascular domains and recurrence risk
Vinicius Tragante, Pieter A. F. M. Doevendans, Hendrik M. Nathoe, Yolanda van der Graaf, Wilko Spiering, Ale Algra, Gert Jan de Borst, Paul I. W. de Bakker, Folkert W. Asselbergs
EUROPEAN HEART JOURNAL (2013)
The risk of resting heart rate on vascular events and mortality in vascular patients
Remy H. H. Bemelmans, Yolanda van der Graaf, Hendrik M. Nathoe, Annemarie M. J. Wassink, Joris W. P. Vernooij, Wilko Spiering, Frank L. J. Visseren
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Differential effects of renin-angiotensin-aldosterone system inhibition, sympathoinhibition and diuretic therapy on endothelial function and blood pressure in obesity-related hypertension: a double-blind, placebo-controlled cross-over trial
Johannes A. N. Dorresteijn, Ilse M. Schrover, Frank L. J. Visseren, Peter G. Scheffer, P. Liam Oey, A. H. (Jan) Danser, Wilko Spiering
JOURNAL OF HYPERTENSION (2013)
Eligibility for percutaneous renal denervation: the importance of a systematic screening
Willemien L. Verloop, Eva E. Vink, Michiel Voskuil, Evert-jan Vonken, Maarten B. Rookmaaker, Michiel L. Bots, Pieter A. Doevendans, Peter J. Blankestijn, Wilko Spiering
JOURNAL OF HYPERTENSION (2013)
Hypertensive target organ damage and the risk for vascular events and all-cause mortality in patients with vascular disease
Joris W. P. Vernooij, Yolanda van der Graaf, Hendrik M. Nathoe, Remy H. H. Bemelmans, Frank L. J. Visseren, Wilko Spiering
JOURNAL OF HYPERTENSION (2013)
Feasibility and Reproducibility of Free Fatty Acid Profiling in Abdominal Adipose Tissue With 1H-Magnetic Resonance Spectroscopy at 3 T: Differences Between Lean and Obese Individuals
Ilse M. Schrover, Tim Leiner, Dennis W. J. Klomp, Jannie P. Wijnen, Cuno S. P. M. Uiterwaal, Wilko Spiering, Frank L. J. Visseren
JOURNAL OF MAGNETIC RESONANCE IMAGING (2014)
The Way to a Man's Stomach Is Through His Heart? The Relation Between Natriuretic Peptide Levels and Adipose Tissue Distribution
Jan Westerink, Wilko Spiering
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Secretory Phospholipase A2-IIA and Cardiovascular Disease
Michael V. Holmes, Tabassome Simon, Holly J. Exeter, Lasse Folkersen, Folkert W. Asselbergs, Montse Guardiola, Jackie A. Cooper, Jutta Palmen, Jaroslav A. Hubacek, Kathryn F. Carruthers, Benjamin D. Horne, Kimberly D. Brunisholz, Jessica L. Mega, Erik P. A. Van Iperen, Mingyao Li, Maarten Leusink, Stella Trompet, Jeffrey J. W. Verschuren, G. Kees Hovingh, Abbas Dehghan, Christopher P. Nelson, Salma Kotti, Nicolas Danchin, Markus Scholz, Christiane L. Haase, Dietrich Rothenbacher, Daniel I. Swerdlow, Karoline B. Kuchenbaecker, Eleonora Staines-Urias, Anuj Goel, Ferdinand van 't Hooft, Karl Gertow, Ulf de Faire, Andrie G. Panayiotou, Elena Tremoli, Damiano Baldassarre, Fabrizio Veglia, Lesca M. Holdt, Frank Beutner, Ron T. Gansevoort, Gerjan J. Navis, Irene Mateo Leach, Lutz P. Breitling, Hermann Brenner, Joachim Thiery, Dhayana Dallmeier, Anders Franco-Cereceda, Jolanda M. A. Boer, Jeffrey W. Stephens, Marten H. Hofker, Alain Tedgui, Albert Hofman, Andre G. Uitterlinden, Vera Adamkova, Jan Pitha, N. Charlotte Onland-Moret, Maarten J. Cramer, Hendrik M. Nathoe, Wilko Spiering, Olaf H. Klungel, Meena Kumari, Peter H. Whincup, David A. Morrow, Peter S. Braund, Alistair S. Hall, Anders G. Olsson, Pieter A. Doevendans, Mieke D. Trip, Martin D. Tobin, Anders Hamsten, Hugh Watkins, Wolfgang Koenig, Andrew N. Nicolaides, Daniel Teupser, Ian N. M. Day, John F. Carlquist, Tom R. Gaunt, Ian Ford, Naveed Sattar, Sotirios Tsimikas, Gregory G. Schwartz, Debbie A. Lawlor, Richard W. Morris, Manjinder S. Sandhu, Rudolf Poledne, Anke H. Maitland-van der Zee, Kay-Tee Khaw, Brendan J. Keating, Pim van der Harst, Jackie F. Price, Shamir R. Mehta, Salim Yusuf, Jaqueline C. M. Witteman, Oscar H. Franco, J. Wouter Jukema, Peter de Knijff, Anne Tybjaerg-Hansen, Daniel J. Rader, Martin Farrall, Nilesh J. Samani, Mika Kivimaki, Keith A. A. Fox, Steve E. Humphries, Jeffrey L. Anderson, S. Matthijs Boekholdt, Tom M. Palmer, Per Eriksson, Guillaume Pare, Aroon D. Hingorani, Marc S. Sabatine, Ziad Mallat, Juan P. Casas, Philippa J. Talmud
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
The daily 10 kcal expenditure deficit: a before-and-after study on low-cost interventions in the work environment
Johannes A. N. Dorresteijn, Yolanda van der Graaf, Kailiang Zheng, Wilko Spiering, Frank L. J. Visseren
BMJ OPEN (2013)
Relation between thyroid-stimulating hormone and the occurrence of cardiovascular events and mortality in patients with manifest vascular diseases
Jan Westerink, Yolanda van der Graaf, Daniel R. Faber, Wilko Spiering, Frank L. J. Visseren
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2012)
The combined use of aspirin, a statin, and blood pressure-lowering agents (polypill components) in clinical practice in patients with vascular diseases or type 2 diabetes mellitus
Melvin Lafeber, Diederick E. Grobbee, Wilko Spiering, Yolanda van der Graaf, Michiel L. Bots, Frank L. J. Visseren
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2013)
The Evening versus Morning Polypill Utilization Study: the TEMPUS rationale and design
Melvin Lafeber, Diederick E. Grobbee, Michiel L. Bots, Simon Thom, Ruth Webster, Anthony Rodgers, Frank L. J. Visseren, Wilko Spiering
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2014)